Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
252.50    2.50 (1.00%)
Bid:
250.00
Ask:
255.00
Spread: 5.00 (2.00%)
Market Cap: £229.38m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Trading Update

Today 07:00

RNS Number : 9762L
Concurrent Technologies PLC
13 July 2026
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

 

13 July 2026

Concurrent Technologies Plc

("Concurrent", the "Company" or the "Group")

 

Trading Update

 

Record H1 performance and strong order momentum

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems and mission critical solutions used in high-performance markets by some of the world's major OEMs, provides an update on trading for the six months to 30 June 2026 ("H1 FY26").

 

Based on its unaudited management accounts for H1 FY26, the Company expects to report record results for a first half, with revenue of approximately £23.1m (H1 FY25: £21.1m) and profit before tax of approximately £3.3m (H1 FY25: £2.7m).

 

Order intake for H1 FY26 was significantly ahead of the prior year at £46.9m, up 110% (H1 FY25 £22.3m), driven by demand across the Group's key geographies and end markets. This included the c.£17m multi-year order secured from a European customer announced in June 2026. Excluding this order, the Group nevertheless achieved record order intake compared to any prior half-year period.

 

The Systems business secured approximately $8m of orders during the period and delivered a profitable first half. The business continues to make progress and is expected to become an increasingly material contributor to Group performance over the medium term. The Products business experienced more modest order intake in the first quarter, followed by an improvement in the second quarter, providing greater revenue visibility into the second half.

 

During H1 FY26, the Group continued to secure further design wins across both its Products and Systems businesses, with a projected lifetime value (LTV) of approximately £129m. These design wins enhance medium-term revenue visibility and underpin the Group's future growth pipeline.

 

The Group is also seeing increased conversion of earlier design wins, secured three to four years ago, into production orders, supporting the transition of pipeline opportunities into revenue.

 

To support anticipated demand, the Group's Colchester manufacturing expansion is progressing to plan, with output capacity expected to approximately double from Q3 2026.

 

The Group has continued to proactively manage industry-wide supply chain challenges, including securing supplier commitments for forecast DRAM requirements through 2026 and into 2027. In addition, following accelerated end-of-life announcements affecting certain Intel processor families, the Group has worked closely with customers and suppliers to secure future programme requirements through appropriate forward procurement arrangements.

 

The Company has entered H2 FY26 with good momentum, demonstrated by the $9.4m contract win announced post period end. Combined with a healthy backlog and pipeline and the expected conversion of design wins into production in H2, the Board believes that the Company is well positioned to at least deliver full year results for 2026 in line with current market expectations*.

 

Miles Adcock, CEO of Concurrent Technologies, commented: "Delivering record first-half results reflects the continued strength of demand across our key markets and the successful execution of our growth strategy across both Products and Systems. The increasing conversion of earlier design wins into production orders, as anticipated, is particularly encouraging, alongside continued new programme wins, which together are enhancing the visibility and quality of future revenues across the Group.

 

"Underlying demand remains strong, and alongside a solid order book, the Group is well positioned for the second half of the year and beyond."

 

*In so far as the Board is aware, consensus market expectations for FY26 are revenues of £53m and profit before tax of £8m.

 

The person responsible for the release of this announcement is Miles Adcock, CEO of Concurrent.

 

Enquiries:

 

Concurrent Technologies Plc Miles Adcock - CEO

Kim Garrod - CFO

 

 

+44 (0)1206 752626

 

Alma Strategic Communications Hannah Campbell / Josh Royston / Will Merison

 

+44 (0)20 3405 0205

 

Investec Bank plc (Financial Adviser, Nominated Adviser and Corporate Broker) Nick Prowting / Virginia Bull / Arnav Kapoor / Tommy Jackson

+44 (0)20 7597 5970

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.concurrent.tech.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRTMTTMTIBBFF
Date   Source Headline
10th Mar 20217:00 amRNSSecond Interim Dividend
16th Dec 20207:00 amRNSPre-Close Trading Update
13th Nov 202011:58 amRNSDirector/PDMR Shareholding
5th Nov 20207:00 amRNSLaunch of high performance Advanced MC Board
21st Oct 20204:02 pmRNSTreasury Shares
20th Oct 20209:07 amRNSTreasury Shares
16th Oct 20207:00 amRNSIssue of Share Options and PDMR dealing
16th Oct 20207:00 amRNSTreasury Shares
6th Oct 20204:50 pmRNSTotal Voting Rights
11th Sep 20203:07 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSInterim Results
21st Aug 20207:00 amRNSNotification of Interim Results
23rd Jul 202011:15 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSRetirement of Director
17th Jun 20202:33 pmRNSResult of AGM
16th Jun 20202:45 pmRNSAGM Statement
9th Jun 20205:17 pmRNSTotal Voting Rights & Director Shareholding
1st Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSHolding(s) in Company
27th May 20204:55 pmRNSTotal Voting Rights & Director Shareholding
22nd May 20202:34 pmRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Appointment
12th May 20207:00 amRNSTotal Voting Rights
30th Apr 20206:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSResults for the year ended 31 December 2019
17th Apr 20207:00 amRNSNotice of Results
26th Mar 20207:00 amRNSDirector Appointment and Results Timing Update
10th Mar 20207:00 amRNSSecond Interim Dividend
14th Feb 20206:06 pmRNSDirector/PDMR Shareholding
12th Feb 202012:18 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSProduct Announcement
24th Jan 20204:29 pmRNSHolding(s) in Company
21st Jan 20207:00 amRNSPost-Close Trading Update
7th Jan 20202:13 pmRNSHolding(s) in Company
7th Jan 20202:10 pmRNSHolding(s) in Company
6th Jan 202012:29 pmRNSHolding(s) in Company
20th Nov 201910:14 amRNSHolding(s) in Company
11th Oct 20191:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
9th Aug 20197:00 amRNSNotice of Interim Results
11th Jun 20198:45 amRNSProduct Announcement
22nd May 20194:41 pmRNSResult of AGM
21st May 20192:30 pmRNSAGM Statement
8th May 20197:00 amRNSDeath of Director
24th Apr 20197:00 amRNSDistribution of Annual Report and Accounts
4th Apr 20197:00 amRNSResults for the year ended 31 December 2018
29th Mar 20197:00 amRNSNotice of Results
14th Mar 20197:00 amRNSSecond Interim Dividend
6th Mar 20197:00 amRNSProduct Announcement
17th Jan 20192:50 pmRNSPost-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.